The global race to develop a vaccine is on, but getting it to market by the end of 2021 is unlikely, the CEO of the Swiss pharmaceuticals giant suggested on Wednesday.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,